Plasminogen and plasminogen activator assembly on the human endothelial cell

Area of Science:

• Biochemistry
• Cell Biology
• Hemostasis

Background:

• The endothelial cell surface plays a crucial role in regulating blood coagulation and fibrinolysis.
• Plasminogen activation is a key step in fibrinolysis, leading to clot dissolution.
• Understanding the regulation of plasmin formation on the cell surface is vital for comprehending vascular health and thrombotic disorders.

Purpose of the Study:

• To investigate the mechanisms of plasmin generation on the endothelial cell surface.
• To identify factors that regulate cell-surface plasmin formation.
• To explore the role of plasmin formation in the nonthrombogenicity of the blood vessel wall.

Main Methods:

• The study likely involved in vitro experiments using endothelial cells, purified proteins (plasminogen, tissue plasminogen activator [t-PA], lipoprotein(a) [Lp(a)]), and inhibitors.
• Techniques may include binding assays, enzyme activity measurements, and potentially cell-based assays to assess plasmin generation and its regulation.

Main Results:

• A 40-kDa protein on the cell surface promotes plasmin formation by bringing together t-PA and plasminogen.
• Conversion of Glu-plasminogen (Glu-PLG) to Lys-plasminogen (Lys-PLG) may occur near the cell surface before plasmin generation.
• Physiological levels of Lp(a) modulate plasminogen activation, while elevated levels may promote a prothrombotic state.
• Cell surface binding protects plasmin and t-PA from their respective inhibitors (alpha 2-plasmin inhibitor and plasminogen activator inhibitor-1 [PAI-1]).

Conclusions:

• The endothelial cell surface provides a microenvironment conducive to plasmin generation.
• Multiple regulatory mechanisms, involving specific proteins and lipoprotein(a), control cell-surface plasmin formation.
• Cell-surface plasmin generation contributes to the blood vessel wall's ability to prevent thrombosis.